Role of external beam radiation therapy in the treatment of thyroid cancer

被引：0
作者：
Vordermark, D. [1 ]
Pelz, T. [1 ]
Sieker, F. [1 ]
机构：
[1] Univ Halle Wittenberg, Univ Klin Strahlentherapie, D-06110 Saale, Germany
来源：
ONKOLOGE | 2010年 / 16卷 / 07期
关键词：
Thyroid cancer; Radiotherapy; IMRT; Guidelines; Toxicity; PROGNOSTIC-FACTORS; CARCINOMA; RADIOTHERAPY; MANAGEMENT; SURVIVAL; SURGERY; CHEMOTHERAPY; MULTICENTER; IRRADIATION; GLAND;
D O I：
10.1007/s00761-010-1871-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Results of retrospective studies on differentiated thyroid cancer suggest that patients with true invasion of adjacent organs (stage T4 in TNM 2002) benefit from external beam radiotherapy regarding locoregional control and in an R2 situation even regarding disease-specific survival. The German MSDS trial could only partly clarify the role of external beam radiotherapy in differentiated thyroid cancer with extracapsular extension. International guidelines currently recognize a small high-risk group which benefits from external beam radiotherapy after optimal surgery and radioiodine treatment. In undifferentiated thyroid cancer external-beam radiotherapy is usually indicated even in the presence of distant metastases. It should be administered with at least 40 Gy and achieves locoregional control in 60-80% of cases. Patients without distant metastases and at least macroscopically complete resection might benefit from trimodal treatment.
引用
收藏
页码：695 / 700
页数：6
相关论文
共 32 条
  • [21] ANAPLASTIC CARCINOMA OF THE THYROID-GLAND TREATED BY RADIATION-THERAPY
    LEVENDAG, PC
    DEPORRE, PMZR
    VANPUTTEN, WLJ
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 26 (01): : 125 - 128
  • [22] Clinical characteristics of poorly differentiated thyroid carcinomas compared with those of classical papillary thyroid carcinomas
    Lin, Jen-Der
    Chao, Tzu-Chieh
    Hsueh, Chuen
    [J]. CLINICAL ENDOCRINOLOGY, 2007, 66 (02) : 224 - 228
  • [23] Management of brain metastases from thyroid carcinoma - A study of 16 pathologically confirmed cases over 25 years
    McWilliams, RR
    Giannini, C
    Hay, ID
    Atkinson, JL
    Stafford, SL
    Buckner, JC
    [J]. CANCER, 2003, 98 (02) : 356 - 362
  • [24] Phase II evaluation of high dose accelerated radiotherapy for anaplastic thyroid carcinoma
    Mitchell, G
    Huddart, R
    Harmer, C
    [J]. RADIOTHERAPY AND ONCOLOGY, 1999, 50 (01) : 33 - 38
  • [25] Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland
    Nutting, CM
    Convery, DJ
    Cosgrove, VP
    Rowbottom, C
    Vini, L
    Harmer, C
    Dearnaley, DP
    Webb, S
    [J]. RADIOTHERAPY AND ONCOLOGY, 2001, 60 (02) : 173 - 180
  • [26] European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
    Pacini, Furio
    Schlumberger, Martin
    Dralle, Henning
    Elisei, Rossella
    Smit, Johannes W. A.
    Wiersinga, Wilmar
    Moreno-Reyes, R.
    Van den Bruel, A.
    Zira, C.
    Feldt-Rasmussen, U.
    Godballe, C.
    Corone, C.
    Borson-Charzot, F.
    Reiners, C.
    Alevizaki, M.
    Duntas, L.
    Vlassopoulou, B.
    Esik, O.
    Mezosi, E.
    Moriarty, M. J.
    Smyth, P.
    Cohen, O.
    Krausz, Y.
    Pellegriti, G.
    Castagna, M. G.
    Marga, M.
    Bioro, T.
    Jarzab, B.
    Carrilho, F.
    de Castro, J. J.
    Limbert, E. S.
    Ioachim, D.
    Mogos, V.
    Ursu, H.
    Roumiantsev, P.
    Troshina, E.
    Hnilica, P.
    Besic, N.
    Zagar, I.
    Gomez, J. M.
    Sanchez-Franco, F.
    Berg, G.
    Tennvall, J.
    Wallin, G. K.
    Meier, C. A.
    Links, T. P.
    Ayvaz, G.
    Uysal, A. R.
    Cherenko, S.
    Larin, O.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 154 (06) : 787 - 803
  • [27] Patel Kepal N, 2006, Cancer Control, V13, P119
  • [28] [Perros P. Royal College of Physicians Thyroid Cancer Royal College of Physicians Thyroid Cancer], 2007, Report of the Thyroid Cancer Guidelines Update Group
  • [29] Acute toxicity of adjuvant radiotherapy in locally advanced differentiated thyroid carcinoma -: First results of the multicenter study differentiated thyroid carcinoma (MSDS)
    Schuck, A
    Biermann, M
    Pixberg, MK
    Müller, SB
    Heinecke, A
    Schober, O
    Willich, N
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2003, 179 (12) : 832 - 839
  • [30] POSTOPERATIVE EXTERNAL BEAM RADIOTHERAPY FOR DIFFERENTIATED THYROID CANCER: OUTCOMES AND MORBIDITY WITH CONFORMAL TREATMENT
    Schwartz, David L.
    Lobo, Mark J.
    Ang, K. Kian
    Morrison, William H.
    Rosenthal, David I.
    Ahamad, Anesa
    Evans, Douglas B.
    Clayman, Gary
    Sherman, Steven I.
    Garden, Adam S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (04): : 1083 - 1091
1234